IceCure Medical
ICCM
13 hedge funds and large institutions have $54.8M invested in IceCure Medical in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
1,541% more capital invested
Capital invested by funds: $3.34M → $54.8M (+$51.4M)
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
86% more funds holding
Funds holding: 7 → 13 (+6)
0.04% more ownership
Funds ownership: 0.04% → 0.08% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$845K |
| 2 |
JP Morgan Chase
New York
|
+$451K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$312K |
| 4 |
Goldman Sachs
New York
|
+$301K |
| 5 |
Jane Street
New York
|
+$237K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$8.69K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Credit Suisse
Zurich,
Switzerland
| $52.5M | +$312K | +1,867 | New |
|
|
AIM
2
ARK Investment Management
St. Petersburg,
Florida
| $1.4M | +$845K | +5,056 | +48% |
|
|
3
Jane Street
New York
| $249K | +$237K | +1,421 | +107% |
|
|
4
JP Morgan Chase
New York
| $247K | +$451K | +2,697 | New |
|
|
5
Goldman Sachs
New York
| $165K | +$301K | +1,800 | New |
|
6
Bank of America
Charlotte,
North Carolina
| $88K | +$35.9K | +215 | +29% |
|
|
BFM
7
Boothbay Fund Management
New York
| $61K | +$111K | +667 | New |
|
|
PCA
8
Personal Capital Advisors
Redwood City,
California
| $45K | +$83.4K | +499 | New |
|
|
SIGI
9
Susquehanna International Group (Ireland)
Dublin,
Ireland
| $38K | +$70.7K | +423 | New |
|
10
UBS Group
Zurich,
Switzerland
| $9K | +$1.17K | +7 | +8% |
|
|
11
Osaic Holdings
Scottsdale,
Arizona
| $5K | -$8.69K | -52 | -48% |
|
12
Morgan Stanley
New York
| $3K | +$5.51K | +33 | New |
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.34K | +8 | +53% |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$1K | -3 | Closed |
|
ICCM Hedge Fund Activity: Q4 2021 in Review
13 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q4 2021, worth a combined $54.8M — up 1,541% from $3.34M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ICCM positions and 1 closed out — a net gain of 6 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $845K. The largest seller was Osaic Holdings, cutting an estimated $8.69K.
- 13 institutional investors held IceCure Medical (ICCM) as of Q4 2021, up from 7 in Q3 2021.
- Funds reported $54.8M of IceCure Medical stock for Q4 2021, up 1,541% quarter-over-quarter.
- 7 funds opened new IceCure Medical positions in Q4 2021 and 1 closed out, a net change of +6 holders.
- The largest IceCure Medical buyer in Q4 2021 was ARK Investment Management, an estimated $845K added.
- The largest IceCure Medical seller in Q4 2021 was Osaic Holdings, an estimated $8.69K sold.
Based on aggregated 13F filings for Q4 2021.